- CRT-pacemakers
- CRT-defibrillators
Cardiac Resynchronization Therapy (CRT) Market size was valued at USD 965.7 million in 2022 and is projected to reach USD 983.4 million by 2029, registering a CAGR of 5.0% from 2023 to 2029. Cardiac Resynchronization therapy is used to treat heart diseases. Devices that are used in cardiac resynchronization therapy are known as CRT devices. Irregular heartbeats are known as arrhythmias and can be caused due to various reasons such as age, damage of the heart, genetic factors and so far used medications. CRT, or biventricular pacing, is used to improve the rhythm of the heart and reduce the symptoms that are associated with arrhythmias in heart failure patients. Heart ventricle contractions in arrhythmic patients are resynchronized by the CRT devices. Global Cardiac Resynchronization Therapy (CRT) Market is the implantable devices with a microcomputer along with an enclosed battery by a tiny titanium metal case. Insulated wires known as leads are implanted along with the device so as to pass the information signals from the heart-to-heart device to carry electrical impulses to the heart. The CRT devices market is expected to show a significant growth rate during the forecast period due to the high prevalence of cardiac diseases. As per the World Health Organisation (WHO), one of the leading causes of death worldwide is cardiovascular disease, and around 17.5 million people died from cardiovascular diseases which accounted for 31% of all global deaths in the year 2012. Cardiovascular diseases can be prevented by addressing behavioral risks like cigarette smoking, an unhealthy diet, and obesity, players in the market are focusing on R&D investments to improve product quality and minimize manufacturing costs, and also focus on the development of devices that are safe to improve compliance of the patient. For example, Medtronic and St. Jude Medical (Abbott laboratories) offer leadless pacemakers for the implantation of the equipment in the right ventricle. Moreover, increase in the usage of MRIs in clinical applications.
Cardiac Resynchronization Therapy (CRT) Market Key Developments:
- In February 2017, RESONATE cardiac resynchronization therapy defibrillator (CRT-D) systems were launched by Boston Scientific and also received CE Mark which is available for treatment of heart failure in patients across the globe.
- In January 2017, Abbott Laboratories acquired St. Jude Medical, Inc., for future growth and to develop a diverse and strong portfolio of medical devices, nutritionals, diagnostics, and established branded generic pharmaceuticals.
Cardiac Resynchronization Therapy Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Cardiac Resynchronization Therapy (CRT) Market Dynamics
Increase in prevalence rate of the heart diseases globally driving the CRT devices market. Rise in the demand of the invasive techniques in treatment of the heart diseases and changes in the life style driving the CRT devices market. Moreover, advancements in the technologies and rise in the adaptability of the CRT devices are fuelling the market of the CRT devices. However, risks in CRT therapy such as surgical site infection, failure in delivering the optimum therapy when it is needed (either extra therapy when it is not needed or no therapy delivered when it is needed), sensitivity towards the device material are hindering the growth of CRT devices market.
North-America Got Significant Share
Cardiac Resynchronization Therapy Market Regional Analysis
Geographically CRT Devices market is divided into five key regions they are North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America expected to be major contributor for CRT devices market owing to factors such as prevalence rates of heart diseases, well established healthcare infrastructure and increase in adaptability rates of CRT devices. Asia-Pacific and Latin American region are expected to witness lucrative growth owing to rapid expansion of industry players within these regions in terms of manufacturing as well as distribution. In addition, increased adaptability rates of a CRT devices and increase in awareness regarding CRT devices are expected to boost the market growth in this region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Cardiac Resynchronization Therapy Market Segmentation
By Type Of Device
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centres
GEOGRAPHY
- North America,
- Europe,
- Asia-Pacific,
- Latin America,
- Middle East & Africa.
Frequently Asked Questions
The cardiac resynchronization therapy market size was valued at USD 965.7 million in 2022
The cardiac resynchronization therapy market's key players are: Medtronic (U.S.) Abbott Laboratories (U.S.) Biotronik (Germany) LivaNova Plc. (UK) Boston Scientific Corporation (U.S.)
The cardiac resynchronization therapy market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary
2. Global Cardiac Resynchronization Therapy (CRT Devices) Market Introduction
2.1. Global Cardiac Resynchronization Therapy (CRT Devices) Market Taxonomy
2.2. Global Cardiac Resynchronization Therapy (CRT Devices) Market Definitions
2.2.1. Device Type
2.2.2. End User
3. Global Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cardiac Resynchronization Therapy (CRT Devices) Market Dynamic Factors - Impact Analysis
4. Global Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cardiac Resynchronization Therapy (CRT Devices) Market, By Device Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. CRT-pacemakers
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. CRT-defibrillators
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Cardiac Resynchronization Therapy (CRT Devices) Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1. Hospitals
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Clinics
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Ambulatory Surgical Centers
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
. Market Opportunity Analysis
7. Global Cardiac Resynchronization Therapy (CRT Devices) Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Region, 2023 - 2029
8. North America Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. Device Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. CRT-pacemakers
8.1.2. CRT-defibrillators
8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Hospitals
8.2.2. Clinics
8.2.3. Ambulatory Surgical Centres
8.3. Country Analysis 2016 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2023 - 2029
8.5. North America Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends
9. Europe Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. Device Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. CRT-pacemakers
9.1.2. CRT-defibrillators
9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Hospitals
9.2.2. Clinics
9.2.3. Ambulatory Surgical Centres
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2023 - 2029
9.5. Europe Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics Trends
10. Asia-Pacific Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. Device Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. CRT-pacemakers
10.1.2. CRT-defibrillators
10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Hospitals
10.2.2. Clinics
10.2.3. Ambulatory Surgical Centres
10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2023 - 2029
10.5. Asia-Pacific Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics Trends
11. Latin America Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2012 - 2012 - 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Device Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. CRT-pacemakers
11.1.2. CRT-defibrillators
11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Hospitals
11.2.2. Clinics
11.2.3. Ambulatory Surgical Centres
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2023 - 2029
11.5. Latin America Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics Trends
12. Middle East and Africa Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Device Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. CRT-pacemakers
12.1.2. CRT-defibrillators
12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Hospitals
12.2.2. Clinics
12.2.3. Ambulatory Surgical Centres
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2023 - 2029
12.5. MEA Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Medtronic (U.S.)
13.2.2. Abbott Laboratories (U.S.)
13.2.3. Biotronik (Germany)
13.2.4. LivaNova Plc. (UK)
13.2.5. Boston Scientific Corporation (U.S.)
14. Research Methodology
15. Key Assumptions and Acronyms
- Medtronic (U.S.)
- Abbott Laboratories (U.S.)
- Biotronik (Germany)
- LivaNova Plc. (UK)
- Boston Scientific Corporation (U.S.)